Cleveland BioLabs
CBLI
#9801
Rank
A$74.27 M
Marketcap
A$4.80
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: A$74.27 Million

As of December 2025 Cleveland BioLabs has a market cap of A$74.27 Million. This makes Cleveland BioLabs the world's 9801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022A$72.1 M6.54%
2021A$67.68 M15.89%
2020A$58.4 M501.17%
2019A$9.71 M-40.03%
2018A$16.19 M-72.04%
2017A$57.93 M167.67%
2016A$21.64 M-58.88%
2015A$52.63 M164.42%
2014A$19.9 M-66.41%
2013A$59.26 M3.52%
2012A$57.24 M-42.21%
2011A$99.05 M-51.88%
2010A$0.20 B176.5%
2009A$74.44 M80.04%
2008A$41.34 M-68.15%
2007A$0.12 B71.71%
2006A$75.61 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
A$31.64 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$1.61 B 2,067.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$268.88 B 361,926.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$383.85 B 516,707.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$160.69 B 216,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$183.00 B 246,289.98%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$147.91 B 199,048.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
A$24.58 M-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.370 T 1,845,699.95%๐Ÿ‡บ๐Ÿ‡ธ USA